RASP OTC
Actavia Life Sciences, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -87.5%
3Y: -95.0%
5Y: -99.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$9K
+97.3% ▲
Capital Expenditures
$4
-233.3% ▼
5Y CAGR: -75.0%
Free Cash Flow
-$9K
+97.3% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$36K
+24.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$936K | -$5M | -$785K | -$687K | -$4M |
| Depreciation & Amort. | $3K | $2K | $314 | $0 | $0 |
| Stock-Based Comp. | $368K | $135K | $43K | $0 | $0 |
| Change in Working Capital | $452K | $48K | -$124K | $71K | $371K |
| Other Non-Cash Items | $28K | $5M | $663K | $303K | $4M |
| Operating Cash Flow | -$93K | -$251K | -$293K | -$313K | -$9K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $100K | $216K | $290K | $341K | $44K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $100K | $216K | $290K | $341K | $44K |
| Net Change in Cash | $7K | -$36K | -$3K | $29K | $36K |
| Cash End of Period | $50K | $14K | $11K | $39K | $75K |
| Free Cash Flow | -$93K | -$251K | -$293K | -$313K | -$9K |